Command Palette

Search for a command to run...

Clinical Trials · NCT02765399

The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Helsinki University Central Hospital
Enrollment
23
Start date
Feb 2015
Locations
1 site, Finland
Primary endpoint
Change in Liver Fat Content
View Liraglutide compound reference